4
<SEC-DOCUMENT>0001140361-20-025370.txt : 20201112
<SEC-HEADER>0001140361-20-025370.hdr.sgml : 20201112
<ACCEPTANCE-DATETIME>20201112163108
ACCESSION NUMBER:		0001140361-20-025370
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20201109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201112
DATE AS OF CHANGE:		20201112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PDS Biotechnology Corp
		CENTRAL INDEX KEY:			0001472091
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				264231384
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37568
		FILM NUMBER:		201307226

	BUSINESS ADDRESS:	
		STREET 1:		25B VREELAND ROAD
		CITY:			FLORHAM PARK
		STATE:			NJ
		ZIP:			07932
		BUSINESS PHONE:		800-208-3343

	MAIL ADDRESS:	
		STREET 1:		25B VREELAND ROAD
		CITY:			FLORHAM PARK
		STATE:			NJ
		ZIP:			07932

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Edge Therapeutics, Inc.
		DATE OF NAME CHANGE:	20090911
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10016834_8k.htm
<DESCRIPTION>8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: SUMMIT
         Document created using EDGARfilings PROfile 7.3.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">WASHINGTON, DC 20549</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">FORM 8-K</div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; color: #000000; font-weight: bold;"> CURRENT REPORT</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">Pursuant to Section 13 or 15(d) of the</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">Securities Exchange Act of 1934</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">Date of Report (Date of earliest event reported): November 9, 2020</div>
      <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">PDS BIOTECHNOLOGY CORPORATION</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">(Exact Name of Registrant as Specified in Charter)</div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb439c71e4424462a97bb39f1131c9863">

          <tr>
            <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><u>Delaware</u></div>
            </td>
            <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><u>001-37568</u></div>
            </td>
            <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><u>26-4231384</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or Other Jurisdiction of Incorporation)</div>
            </td>
            <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Commission File Number)</div>
            </td>
            <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer Identification No.)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; color: #000000; font-weight: bold;"><u> <br>
        </u></div>
      <div style="text-align: center; color: #000000; font-weight: bold;"><u>25B Vreeland Road</u></div>
      <div style="text-align: center; color: #000000; font-weight: bold;"><u>Florham Park NJ 07932</u></div>
      <div style="text-align: center; color: #000000; font-weight: bold;">(Address of Principal Executive Offices, and Zip Code)</div>
      <div style="text-align: center; color: #000000;"><u>(800) 208-3343</u></div>
      <div style="text-align: center; color: #000000; font-weight: bold;">Registrant&#8217;s Telephone Number, Including Area Code</div>
      <div style="text-align: center; color: #000000; font-weight: bold;"> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000; text-align: center;"></div>
      <div style="text-align: center; color: #000000; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>
      <div style="color: #000000;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="font-style: italic;">see</font>
        General Instruction A.2. below):</div>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;"> </div>
      <div style="color: #000000;">
        <table cellspacing="0" cellpadding="0" id="zc186139eedcd4ba59d97ff03e56bfa4b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="z09c27ad9ed604a5d905bcb4244706dbf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="z45189f4e1d364cc8a44b0d01d438355b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="zfdcaf7159cf349db9bb8f23c959a0406" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;">Securities registered pursuant to Section 12(b) of the Act:</div>
      <div style="color: #000000;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf6df2ab0be0e47f8bb91b2a6850079cd">

          <tr>
            <td style="width: 34.99%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Trading Symbol(s)</div>
            </td>
            <td style="width: 35.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
            </td>
          </tr>
          <tr>
            <td style="width: 34.99%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Common Stock, par value $0.00033 per share</div>
            </td>
            <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">PDSB</div>
            </td>
            <td style="width: 35.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">The Nasdaq Capital Market</div>
            </td>
          </tr>

      </table>
      <div style="color: #000000;"> <br>
      </div>
      <div style="color: #000000;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17
        CFR &#167;240.12b-2 of this chapter).</div>
      <div style="color: #000000;"> <br>
      </div>
      <div style="text-align: right; color: #000000;">Emerging growth company &#9746;</div>
      <div style="text-align: right; color: #000000;"> <br>
      </div>
      <div style="color: #000000;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to
        Section 13(a) of the Exchange Act. &#9746;</div>
      <div style="color: #000000;"> <br>
      </div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z2bad23fc60264f8bad1ef6b222c9e461" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 11.52%; vertical-align: top;">
                <div style="margin-right: 12.75pt; color: #000000; font-weight: bold;">Item 2.02</div>
              </td>
              <td style="width: 88.48%; vertical-align: top;">
                <div style="color: #000000; font-weight: bold;">Results of Operations and Financial Conditions.</div>
              </td>
            </tr>

        </table>
      </div>
      <div></div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On November 11, 2020, PDS Biotechnology Corporation (the &#8220;Company&#8221;) issued a press release announcing its financial results for the three and nine months ended September 30, 2020
        and an update on the Company&#8217;s operations. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In accordance with General Instruction B.2 of Form 8-K, the information set forth in this Current Report on Form 8-K (including Exhibit 99.1) is deemed to be &#8220;furnished&#8221; and shall
        not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any
        filing made by the Company under the Exchange Act or Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z2850795325a148ee939717e5d206349e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 11.52%; vertical-align: top;">
                <div style="color: #000000; font-weight: bold;">Item 8.01</div>
              </td>
              <td style="width: 88.48%; vertical-align: top;">
                <div style="color: #000000; font-weight: bold;">Results of Operations and Financial Conditions.</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On November 9, 2020, the Company issued a press release announcing the opening of the Company&#8217;s VERSATILE-002 Phase 2 clinical trial evaluating the combination of PDS0101 and
        KEYTRUDA&#174; (pembrolizumab) for the first-line treatment of head and neck cancer.&#160; A copy of the press release is filed as Exhibit 99.2 hereto and incorporated herein by reference.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On November 10, 2020, the Company issued a press release announcing progress on the Company&#8217;s co-development program with Farmacore Biotechnology for a Versamune&#174;-based vaccine
        aimed at preventing COVID-19 infection.&#160; A copy of the press release is filed as Exhibit 99.3 hereto and incorporated herein by reference.</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z2c93071743254c2b8a9c0cb4c7408ee1" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 11.52%; vertical-align: top;">
                <div style="color: #000000; font-weight: bold;">Item 9.01</div>
              </td>
              <td style="width: 88.48%; vertical-align: top;">
                <div style="color: #000000; font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="color: #000000; font-weight: bold;"> <br>
      </div>
      <div style="color: #000000; font-weight: bold;">(d) Exhibits.</div>
      <div style="color: #000000; font-weight: bold;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z344a72d5a7064083951d998f7b244f6d">

          <tr>
            <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Exhibit</div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Number</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 94%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center;"><a href="brhc10016834_ex99-1.htm">99.1</a></div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 94%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Press release dated November 11, 2020.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center;"><a href="brhc10016834_ex99-2.htm">99.2</a></div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">&#160;</td>
            <td style="width: 94%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Press release dated November 9, 2020.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center;"><a href="brhc10016834_ex99-3.htm">99.3</a></div>
            </td>
            <td style="width: 1%;